The burden of obesity in Egypt M Aboulghate, A Elaghoury, I Elebrashy, N Elkafrawy, G Elshishiney, ... Frontiers in public health 9, 718978, 2021 | 67 | 2021 |
Healthcare financing in Egypt: a systematic literature review. A Fasseeh, B ElEzbawy, W Adly, R ElShahawy, M George, S Abaza, ... Journal of the Egyptian Public Health Association 97 (1), 1, 2022 | 34 | 2022 |
Burden of Atopic Dermatitis in Adults and Adolescents: a Systematic Literature Review SAZK Ahmad N. Fasseeh, Baher Elezbawy, Nada Korra, Mohamed Tannira, Hala ... Dermatology and Therapy, 2022 | 28 | 2022 |
Criteria and scoring functions used in multi-criteria decision analysis and value frameworks for the assessment of rare disease therapies: a systematic literature review T Zelei, ND Mendola, B Elezbawy, B Németh, JD Campbell PharmacoEconomics-open 5 (4), 605-612, 2021 | 15 | 2021 |
Potential criteria for frameworks to support the evaluation of innovative medicines in upper middle-income countries—a systematic literature review on value frameworks and … I Jakab, B Németh, B Elezbawy, MA Karadayı, H Tozan, S Aydın, J Shen, ... Frontiers in Pharmacology 11, 1203, 2020 | 12 | 2020 |
A multi-criteria decision analysis (MCDA) tool for purchasing off-patent oncology medicines in Egypt B Elezbawy, AN Fasseeh, A Sedrak, R Eldessouki, M Gamal, M Eldebeiky, ... Journal of Pharmaceutical Policy and Practice 15 (1), 10, 2022 | 5 | 2022 |
Humanistic and economic burden of atopic dermatitis for adults and adolescents in the Middle East and Africa region B Elezbawy, AN Fasseeh, E Fouly, M Tannira, H Dalle, S Aderian, ... Dermatology and Therapy 13 (1), 131-146, 2023 | 4 | 2023 |
A roadmap toward implementing health technology assessment in Egypt AN Fasseeh, B Elezbawy, M Gamal, A Seyam, A Abourawash, M George, ... Frontiers in public health 10, 896175, 2022 | 4 | 2022 |
A multicriteria decision analysis (MCDA) tool to purchase implantable medical devices in Egypt B Elezbawy, AN Fasseeh, B Németh, M Gamal, M Eldebeiky, R Refaat, ... BMC Medical Informatics and Decision Making 22 (1), 289, 2022 | 3 | 2022 |
Supporting role of non-governmental health insurance schemes in the implementation of universal health coverage in developing countries T Almási, E Abul-Magd, M George, F Arnaiz, B Elezbawy, B Nagy, Z Kaló JOURNAL OF HEALTH POLICY AND OUTCOMES RESEARCH 1, 1-9, 2020 | 3 | 2020 |
PNS178 private health insurance perception of their role afterward universal health insurance in Egypt E Abouelmaged, B Elezbawy, T Almási, AN Fasseeh, A Khalil, H Dawood, ... Value in Health 22, S791, 2019 | 3 | 2019 |
The humanistic and economic burden of atopic dermatitis among adults and adolescents in Saudi Arabia B Elezbawy, AN Fasseeh, E Fouly, LCA Esba, H Al Abdulkarim, ... Journal of Medical Economics 25 (1), 1231-1239, 2022 | 2 | 2022 |
HPR180 eligibility of orphan drugs for preferential reimbursement in Egypt AN Fasseeh, B Elezbawy, N Korra, M Roushdy, A Seyam, N Hayek, ... Value in Health 25 (12), S265, 2022 | 2 | 2022 |
POSB205 Framework for Implementing Cost-Effectiveness Thresholds in Egypt AN Fasseeh, B Elezbawy, N Korra, AS Sedrak, MG Kirollos, R Eldessouki, ... Value in Health 25 (1), S145, 2022 | 2 | 2022 |
PNS121 PRIVATE HEALTH INSURANCE COLLABORATION WITH PHARMACEUTICAL COMPANIES IN EGYPT E Abouelmaged, AN Fasseeh, B Elezbawy, A Khalil, H Dawood, S Askar, ... Value in Health 22, S782, 2019 | 1 | 2019 |
PHP178-ROLE OF SUPPLEMENTARY AND COMPLEMENTARY PRIVATE HEALTH INSURANCE IN SELECTED COUNTRIES T Almasi, AN Fasseeh, B Elezbawy, M George, E Abouelmaged, F Arnaiz, ... Value in Health 21, S180, 2018 | 1 | 2018 |
Burden of progressive supranuclear palsy: a systematic literature review S Chen, I Jakab, T Zelei, L Szilberhorn, R Bendes, B Elezbawy, Z Kalo, ... MOVEMENT DISORDERS 33, S414-S415, 2018 | 1 | 2018 |
Strategic Approaches to Reducing the Burden of Atopic Dermatitis in the Middle East and Africa Region B Elezbawy, M Farghaly, A Al Lafi, M Gamal, M Metni, W Visser, ... Value in Health Regional Issues 42, 100987, 2024 | | 2024 |
Development of the Emirates Multi-Criteria Decision Analysis Tool for Orphan Drugs KA Alnaqbi, B Elezbawy, AN Fasseeh, AR Bangash, A Elshamy, H Shendi, ... Cureus 16 (2), 2024 | | 2024 |
EE329 Budget Impact Analysis of Adding Risankizumab and Upadacitinib for the Treatment of Inflammatory Bowel Disease in the Kingdom of Saudi Arabia M Mosli, A Almutairdi, AK Abdulrahman, AN Fasseeh, A Abd-El Aziz, ... Value in Health 26 (12), S114, 2023 | | 2023 |